Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819071) titled 'EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS' on Sept. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Pierre Fabre Dermo Cosmetique
Condition:
Atopic Dermatitis (AD)
Intervention:
Other: Tested Emollient RV5258A
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 3, 2025
Target Sample Size: 33
Countries of Recruitment:
Poland
To know more, visit https://clinica...